The Peter Joseph Pappas Research Grants from the Preeclampsia Foundation fund research to develop new diagnostics and treatments for preeclampsia and related pregnancy disorders, aiming to avoid pre-term delivery.
Funder: Preeclampsia Foundation
Due Dates: August 14, 2026: Letter of Intent (LOI) deadline — LOIs due by 5:00 PM ET, submitted via Proposal Central
Funding Amounts: Up to $200,000 total awarded annually; multiple two-year grants may be funded.
Summary: Supports innovative research to eliminate the need for pre-term delivery as a treatment for severe preeclampsia, HELLP syndrome, and related hypertensive pregnancy disorders.
Key Information: LOI submission is required; see application instructions for details.
The Peter Joseph Pappas Research Grants, offered by the Preeclampsia Foundation, fund cutting-edge scientific research aimed at eliminating pre-term delivery as a treatment for severe preeclampsia, HELLP syndrome, and related hypertensive pregnancy disorders. This program supports projects that advance the understanding of the molecular, genetic, and cellular mechanisms underlying preeclampsia, as well as the development of novel therapeutics and diagnostic tools. The grants are designed to foster a collaborative research environment and accelerate progress toward better outcomes for mothers and babies affected by these conditions.